What Happens When a Key Fund Manager Leaves an AIF or PE Fund?
Understanding the Manager Decision
When a named key person departs mid-fund-life, what happens next is governed entirely by the fund's own documents, not by market convention or a verbal reassurance from the remaining team. The specific mechanics — suspension of the investment period, an investor vote, or simply a substitution — vary fund to fund.
Reading Evidence and Attribution
Most well-drafted PPMs include a key-person clause naming specific individuals whose departure triggers a defined process: typically an automatic suspension of new investments until investors vote to continue with a replacement, extend a cure period, or wind down the fund.
Where Manager Diligence Breaks
The common failure is assuming this scenario is unlikely enough to skip reading the relevant clause before committing. Key-person departures happen regularly in the industry — during due diligence is the only point where an investor still has leverage to ask about it.
Making the Selection Decision
Before committing, read the fund's key-person clause directly and confirm: which named individuals trigger it; what the automatic consequence is (suspension, vote, or continuation); the length of any cure period; and what voting threshold among investors is needed to approve a replacement or wind-down.
The time to understand a key-person departure is before it happens, when the clause can still inform the commitment decision — not after, when the investor's only options are the ones already written into the document.
Key takeaways
- What happens after a key-person departure is governed entirely by the fund's own documents, not convention.
- A well-drafted key-person clause names specific individuals and defines an automatic consequence.
- Key-person departures happen regularly in the industry — read the clause before committing, not after.
- Confirm the cure period length and investor voting threshold needed to approve a replacement.
More in Fund Manager Selection and Due Diligence
Continue with the other chapters in this module.
Related questions
What should an investor verify first?
Which specific named individuals trigger the fund's key-person clause if they depart.
Which documents matter most?
The Private Placement Memorandum's key-person clause, read directly rather than summarized.
What is the main downside to test?
Assuming a key-person departure is unlikely enough to skip reading the relevant clause before committing.
How should the final decision be made?
After confirming the cure period and the investor voting threshold needed to approve a replacement or wind-down.
Need personalized advice?
Schedule a conversation about your private market allocation goals.
Request an advisory call